Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
3
Neutral
1
Bullish
10
Bearish
30
Neutral
1
Bullish
15
Bearish
27
Neutral
0
Bullish
5
Bearish
3
Neutral
1
Bullish
10
Bearish
3
Neutral
1
Bullish
10
Bearish
27
Neutral
0
Bullish
5
Bearish
27
Neutral
0
Bullish
5
Bearish
27
Neutral
0
Bullish
5
Investor Presentation
Q1 FY27
Investor Presentation
Q2 FY26
Indo Borax & Chemicals Limited manufactures boron-based products including boric acid technical and IP grades, Di-Sodium Octaborate Tetrahydrate (DOT), and plans to add Boron oxide and Zinc Borate; its main plant is at Pithampur, Madhya Pradesh, and the company holds FDA and BIS approvals for IP-grade boric acid used in pharma and personal care applications.
Q1 FY27 performance was materially strong: operating revenue of Rs. 70.36 crore (+31% year-on-year), EBITDA of Rs. 19.8 crore (+62%) with a 28.1% margin, and PAT of Rs. 16.25 crore (+59%), driven by higher realizations, improved capacity utilization and better commercial execution after new promoter-led management changes instituted in 2026.
Management completed a strategic acquisition of 64.26% of Kronox Lab Sciences for about Rs. 250 crore, funded via internal accruals, planned sale of non-core Mumbai assets, a term loan, and promoter contingencies; the deal is intended to provide global distribution reach, product adjacencies, and immediate cost and cross-selling synergies.
The company has explicit medium-term growth initiatives including Rs. 50 crore capex for Boron oxide and Boric acid debottlenecking, scaling DOT (target 1,500 tonnes this year versus prior ~900 tonnes), and leveraging Kronox’s global distributors to expand exports, with management expecting Kronox to scale 3x–3.5x post Dahej capex by FY29–31.
Chemicals & Petrochemicals
Commodity Chemicals
1,326 Cr
Low Risk
23.6
35.0
1.5
3.4
543.00
233.00
Sales CAGR
Profit CAGR
ROE
ROCE
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
516.50 | 1,563 Cr | 19.14 | 1.17 | 0.99 | 0.17 | 2.94 | 3.55 | ||
117.65 | 1,449 Cr | -9.56 | 0.93 | 0.00 | -10.74 | -2.87 | -3.20 | ||
102.45 | 1,353 Cr | -1828.81 | 0.00 | 0.00 | 9.60 | 103.10 | -7.07 | ||
403.60 | 1,326 Cr | 23.56 | 3.43 | 0.24 | 11.09 | 14.48 | 13.91 | ||
113.90 | 1,224 Cr | 8.82 | 0.94 | 0.88 | 10.17 | 11.74 | 6.52 | ||
77.01 | 1,036 Cr | 9.58 | 0.62 | 1.57 | 6.01 | 8.39 | 5.02 | ||
404.00 | 988 Cr | 38.56 | 6.42 | 0.00 | 13.16 | 12.77 | 5.55 | ||
| Median: 7 Co. | — | 117.65 | 1,326 Cr | 9.58 | 0.94 | 0.24 | 9.60 | 11.74 | 5.02 |
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Indo Borax & Chemicals Ltd (INDOBORAX) is currently trading at 403.60 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Indo Borax & Chemicals Limited manufactures boron-based products including boric acid technical and IP grades, Di-Sodium Octaborate Tetrahydrate (DOT), and plans to add Boron oxide and Zinc Borate; its main plant is at Pithampur, Madhya Pradesh, and the company holds FDA and BIS approvals for IP-grade boric acid used in pharma and personal care applications. Q1 FY27 performance was materially strong: operating revenue of Rs. 70.36 crore (+31% year-on-year), EBITDA of Rs. 19.8 crore (+62%) with a 28.1% margin, and PAT of Rs. 16.25 crore (+59%), driven by higher realizations, improved capacity utilization and better commercial execution after new promoter-led management changes instituted in 2026. Management completed a strategic acquisition of 64.26% of Kronox Lab Sciences for about Rs. 250 crore, funded via internal accruals, planned sale of non-core Mumbai assets, a term loan, and promoter contingencies; the deal is intended to provide global distribution reach, product adjacencies, and immediate cost and cross-selling synergies. The company has explicit medium-term growth initiatives including Rs. 50 crore capex for Boron oxide and Boric acid debottlenecking, scaling DOT (target 1,500 tonnes this year versus prior ~900 tonnes), and leveraging Kronox’s global distributors to expand exports, with management expecting Kronox to scale 3x–3.5x post Dahej capex by FY29–31.
Over the past 52 weeks, Indo Borax & Chemicals Ltd has traded between a low of ₹233.00 and a high of ₹543.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Indo Borax & Chemicals Ltd has a market capitalization of approximately 1,326.44. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Indo Borax & Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 23.56 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,326.44 Cr, Indo Borax & Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Indo Borax & Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Indo Borax & Chemicals Ltd is 23.56. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Indo Borax acquired 64.26% of Kronox Lab Sciences by purchasing 2,38,44,000 equity shares.
Indo Borax acquired 2,38,44,000 equity shares, representing a 64.26% stake in Kronox Lab Sciences.
Indo Borax has approved acquiring 64.26% of Kronox, involving the purchase of 2.38 crore equity shares from the promoters.
Indo Borax approved the acquisition of a 64.26% stake in Kronox Lab Sciences through a share purchase agreement for an aggregate ₹246.12 crore.
